Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2019 Dec 10;13(12):1492-1500.
doi: 10.1093/ecco-jcc/jjz094.

Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study

Ivan Guerra  1 Luis Bujanda  2   3 Jesús Castro  4 Olga Merino  5 Joan Tosca  6 Blau Camps  7 Ana Gutiérrez  3   8 Jordi Gordillo Ábalos  9 Luisa de Castro  10 Marisa Iborra  3   11 Ana Y Carbajo  12 Carlos Taxonera  13 Iago Rodríguez-Lago  14 Francisco Mesonero  15 Ruth de Francisco  16 Gonzalo J Gómez-Gómez  17 María Chaparro  3   18 Carlos A Tardillo  19 Montserrat Rivero  20 Alicia Algaba  1 Eduardo Martín Arranz  21 Fiorella Cañete  3   22 Raquel Vicente  23 Beatriz Sicilia  24 Beatriz Antolín  25 Vanessa Prieto  26 Lucía Márquez  27 José M Benítez  28 Patricia Camo  29 Marta Piqueras  30 Carla J Gargallo  31 Esther Hinojosa  32 José M Huguet  33 José L Pérez Calle  34 Manuel Van Domselaar  35 Cristina Rodriguez  36 Xavier Calvet  3   37 Carmen Muñoz-Villafranca  38 Mariana F García-Sepulcre  39 Patricia Munoz-Garrido  2   3 Agnès Fernández-Clotet  4 Laura Gómez Irwin  5 Sherly Hernández  6 Jordi Guardiola  7   40 Laura Sempere  8 Carlos González Muñoza  9 Vicent Hernández  10 Belén Beltrán  3   11 Jesús Barrio  12 Cristina Alba  13 Irene Moraleja  14 Antonio López-Sanromán  15 Sabino Riestra  16 Pilar Martínez Montiel  17 Ana Garre  3   18 Laura Arranz  19 María José García  20 María Dolores Martín Arranz  21 Pilar Corsino  23 Lara Arias  24 Luis Fernández-Salazar  25 Alejandra Fernández-Pordomingo  26 Montserrat Andreu  27 Eva Iglesias  28 Yolanda Ber  29 Raquel Mena  30 María Teresa Arroyo Villarino  31 María Mora  32 Lucía Ruiz  33 Pilar López-Serrano  34 Isabel Blazquez  35 Albert Villoria  3   36 María Fernández  37 Fernando Bermejo  1 Jesus M Banales  2   3   41 Eugeni Domènech  3   22 Javier P Gisbert  3   18 Spanish GETECCU group (ENEIDA Project)
Affiliations
Observational Study

Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study

Ivan Guerra et al. J Crohns Colitis. .

Abstract

Background and aims: Primary sclerosing cholangitis [PSC] is usually associated with inflammatory bowel disease [IBD]. An increased risk of malignancies, mainly colorectal cancer [CRC] and cholangiocarcinoma [CCA], has been reported in PSC-IBD patients. Our aim was to determine the clinical characteristics and management of PSC in IBD patients, and the factors associated with malignancies.

Methods: PSC-IBD patients were identified from the Spanish ENEIDA registry of GETECCU. Additional data were collected using the AEG-REDCap electronic data capture tool.

Results: In total, 277 PSC-IBD patients were included, with an incidence rate of 61 PSC cases per 100 000 IBD patient-years, 69.7% men, 67.5% ulcerative colitis and mean age at PSC diagnosis of 40 ± 16 years. Most patients [85.2%] were treated with ursodeoxycholic acid. Liver transplantation was required in 35 patients [12.6%] after 79 months (interquartile range [IQR] 50-139). It was more common in intra- and extrahepatic PSC compared with small-duct PSC (16.3% vs 3.3%; odds ratio [OR] 5.7: 95% confidence interval [CI] = 1.7-19.3). The incidence rate of CRC since PSC diagnosis was 3.3 cases per 1000 patient-years [95% CI = 1.9-5.6]. Having symptoms of PSC at PSC diagnosis was the only factor related to an increased risk of CRC after IBD diagnosis [hazard ratio= 3.3: 95% CI = 1.1-9.9]. CCA was detected in seven patients [2.5%] with intra- and extrahepatic PSC, with median age of 42 years [IQR 39-53], and presented a lower life expectancy compared with patients without CCA and patients with or without CRC.

Conclusions: PSC-IBD patients with symptoms of PSC at PSC diagnosis have an increased risk of CRC. CCA was only diagnosed in patients with intra- and extrahepatic PSC and was associated with poor survival.

Keywords: Primary sclerosing cholangitis; inflammatory bowel disease; malignancy.

PubMed Disclaimer

Publication types

MeSH terms

LinkOut - more resources